C

Conor Steuer

Emory University

ORCID: 0000-0001-6528-6319

Publishes on Lung Cancer Treatments and Mutations, Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers. 292 papers and 6.6k citations.

PubIndex Score81Top 19% · early-careerHow it's scored

292Publications

6.6kTotal Citations

First publication: 2014First senior author: 2015

Lung Cancer Treatments and Mutations Head and Neck Cancer Studies Cancer Immunotherapy and Biomarkers PI3K/AKT/mTOR signaling in cancer Chronic Lymphocytic Leukemia Research

Top publicationsby citations

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer

Daniel A. Goldstein, Alona Zer, Conor Steuer et al.|JNCI Journal of the National Cancer Institute|2017

Cited by 102

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

Nabil F. Saba, Christine H. Chung, Conor Steuer et al.|Nature Medicine|2023

Cited by 76

The evolving landscape of salivary gland tumors

Conor Steuer, Nabil F. Saba, Glenn J. Hanna et al.|CA A Cancer Journal for Clinicians|2023

Cited by 50